Real-world study backs PCI for symptomatic stable CAD

Percutaneous revascularisation for symptomatic stable coronary artery disease is associated with a high degree of procedural success and an “excellent” safety profile, an Australian study shows.
Despite increasing patient and procedural complexity, Melbourne-led cardiologists report an overall mortality rate of less than 0.1% and a significant drop in major bleeding rates.
The findings will likely inform shared decision-making and support the use of percutaneous coronary intervention (PCI) “in carefully selected patients with symptoms refractory to medical therapy”, the researchers say.
Their observational multicentre study, published in Heart, Lung and Circulation, included participants in the prospective Melbourne Interventional Group Registry who underwent PCI for symptomatic stable coronary artery disease between 2005 and 2018.